Abstract
The inability to properly extinguish fear memories constitutes the foundation of several anxiety disorders, including panic disorder. Recent findings show that boosting prefrontal cortex synaptic plasticity potentiates fear extinction, suggesting that therapies that augment synaptic plasticity could prove useful in rescue of fear extinction impairments in this group of disorders. Previously, we reported that mice with selective deregulation of neurotrophic tyrosine kinase receptor, type 3 expression (TgNTRK3) exhibit increased fear memories accompanied by impaired extinction, congruent with an altered activation pattern of the amygdala—hippocampus—medial prefrontal cortex fear circuit. Here we explore the specific role of neurotrophin 3 and its cognate receptor in the medial prefrontal cortex, and its involvement in fear extinction in a pathological context. In this study we combined molecular, behavioral, in vivo pharmacology and ex vivo electrophysiological recordings in TgNTRK3 animals during contextual fear extinction processes. We show that neurotrophin 3 protein levels are increased upon contextual fear extinction in wild-type animals but not in TgNTRK3 mice, which present deficits in infralimbic long-term potentiation. Importantly, infusion of neurotrophin 3 to the medial prefrontal cortex of TgNTRK3 mice rescues contextual fear extinction and ex vivo local application improves medial prefrontal cortex synaptic plasticity. This effect is blocked by inhibition of extracellular signal-regulated kinase phosphorylation through peripheral administration of SL327, suggesting that rescue occurs via this pathway. Our results suggest that stimulating neurotrophin 3-dependent medial prefrontal cortex plasticity could restore contextual fear extinction deficit in pathological fear and could constitute an effective treatment for fear-related disorders.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Aghajanian GK, Rasmussen K (1989). Intracellular studies in the facial nucleus illustrating a simple new method for obtaining viable motoneurons in adult rat brain slices. Synapse 3: 331–338.
Ammendrup-Johnsen I, Naito Y, Craig AM, Takahashi H (2015). Neurotrophin-3 Enhances the Synaptic Organizing Function of TrkC-Protein Tyrosine Phosphatase sigma in Rat Hippocampal Neurons. J Neurosci 35: 12425–12431.
Armengol L, Gratacos M, Pujana MA, Ribases M, Martin-Santos R, Estivill X (2002). 5' UTR-region SNP in the NTRK3 gene is associated with panic disorder. Mol Psychiatry 7: 928–930.
Collin C, Vicario-Abejon C, Rubio ME, Wenthold RJ, McKay RD, Segal M (2001). Neurotrophins act at presynaptic terminals to activate synapses among cultured hippocampal neurons. Eur J Neurosci 13: 1273–1282.
Dierssen M, Gratacos M, Sahun I, Martin M, Gallego X, Amador-Arjona A et al (2006). Transgenic mice overexpressing the full-length neurotrophin receptor TrkC exhibit increased catecholaminergic neuron density in specific brain areas and increased anxiety-like behavior and panic reaction. Neurobiol Dis 24: 403–418.
Feng G, Mellor RH, Bernstein M, Keller-Peck C, Nguyen QT, Wallace M et al (2000). Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP. Neuron 28: 41–51.
Fischer A, Radulovic M, Schrick C, Sananbenesi F, Godovac-Zimmermann J, Radulovic J (2007). Hippocampal Mek/Erk signaling mediates extinction of contextual freezing behavior. Neurobiol Learn Mem 87: 149–158.
Gratacos M, Nadal M, Martin-Santos R, Pujana MA, Gago J, Peral B et al (2001). A polymorphic genomic duplication on human chromosome 15 is a susceptibility factor for panic and phobic disorders. Cell 106: 367–379.
Han KA, Woo D, Kim S, Choii G, Jeon S, Won SY et al (2016). Neurotrophin-3 Regulates Synapse Development by Modulating TrkC-PTPsigma Synaptic Adhesion and Intracellular Signaling Pathways. J Neurosci 36: 4816–4831.
Harvey BH, Shahid M (2012). Metabotropic and ionotropic glutamate receptors as neurobiological targets in anxiety and stress-related disorders: focus on pharmacology and preclinical translational models. Pharmacol Biochem Behav 100: 775–800.
Joo W, Hippenmeyer S, Luo L (2014). Neurodevelopment. Dendrite morphogenesis depends on relative levels of NT-3/TrkC signaling. Science 346: 626–629.
Lessmann V (1998). Neurotrophin-dependent modulation of glutamatergic synaptic transmission in the mammalian CNS. Gen Pharmacol 31: 667–674.
Li R, Wu Y, Jiang D (2014). NT-3 attenuates the growth of human neuron cells through the ERK pathway. Cytotechnology 68: 659–664.
Lissek S, Powers AS, McClure EB, Phelps EA, Woldehawariat G, Grillon C et al (2005). Classical fear conditioning in the anxiety disorders: a meta-analysis. Behav Res Ther 43: 1391–1424.
Lissek S, Rabin SJ, McDowell DJ, Dvir S, Bradford DE, Geraci M et al (2009). Impaired discriminative fear-conditioning resulting from elevated fear responding to learned safety cues among individuals with panic disorder. Behav Res Ther 47: 111–118.
Marek R, Coelho CM, Sullivan RK, Baker-Andresen D, Li X, Ratnu V et al (2011). Paradoxical enhancement of fear extinction memory and synaptic plasticity by inhibition of the histone acetyltransferase p300. J Neurosci 31: 7486–7491.
McAllister AK, Katz LC, Lo DC (1999). Neurotrophins and synaptic plasticity. Annu Rev Neurosci 22: 295–318.
Michael T, Blechert J, Vriends N, Margraf J, Wilhelm FH (2007). Fear conditioning in panic disorder: Enhanced resistance to extinction. J Abnorm Psychol 116: 612–617.
Milad MR, Quirk GJ (2002). Neurons in medial prefrontal cortex signal memory for fear extinction. Nature 420: 70–74.
Muinos-Gimeno M, Guidi M, Kagerbauer B, Martin-Santos R, Navines R, Alonso P et al (2009). Allele variants in functional MicroRNA target sites of the neurotrophin-3 receptor gene (NTRK3) as susceptibility factors for anxiety disorders. Hum Mutat 30: 1062–1071.
Parsons RG, Ressler KJ (2013). Implications of memory modulation for post-traumatic stress and fear disorders. Nat Neurosci 16: 146–153.
Paxinos G, Franklin KBJ The mouse brain in stereotaxic coordinates. Academic Press: New York; (2001).
Peters J, Dieppa-Perea LM, Melendez LM, Quirk GJ (2010). Induction of fear extinction with hippocampal-infralimbic BDNF. Science 328: 1288–1290.
Quirk GJ, Mueller D (2008). Neural mechanisms of extinction learning and retrieval. Neuropsychopharmacology 33: 56–72.
Reichardt LF (2006). Neurotrophin-regulated signalling pathways. Philos Trans R Soc Lond B Biol Sci 361: 1545–1564.
Santini E, Ge H, Ren K, Pena de Ortiz S, Quirk GJ (2004). Consolidation of fear extinction requires protein synthesis in the medial prefrontal cortex. J Neurosci 24: 5704–5710.
Santos M, D'Amico D, Dierssen M (2015). From neural to genetic substrates of panic disorder: Insights from human and mouse studies. Eur J Pharmacol 759: 127–141.
Santos M, D'Amico D, Spadoni O, Amador-Arjona A, Stork O, Dierssen M (2013). Hippocampal hyperexcitability underlies enhanced fear memories in TgNTRK3, a panic disorder mouse model. J Neurosci 33: 15259–15271.
Sierra-Mercado D, Padilla-Coreano N, Quirk GJ (2011). Dissociable roles of prelimbic and infralimbic cortices, ventral hippocampus, and basolateral amygdala in the expression and extinction of conditioned fear. Neuropsychopharmacology 36: 529–538.
Sotres-Bayon F, Bush DE, LeDoux JE (2007). Acquisition of fear extinction requires activation of NR2B-containing NMDA receptors in the lateral amygdala. Neuropsychopharmacology 32: 1929–1940.
Sotres-Bayon F, Quirk GJ (2010). Prefrontal control of fear: more than just extinction. Curr Opin Neurobiol 20: 231–235.
Takahashi H, Arstikaitis P, Prasad T, Bartlett TE, Wang YT, Murphy TH et al (2011). Postsynaptic TrkC and presynaptic PTPsigma function as a bidirectional excitatory synaptic organizing complex. Neuron 69: 287–303.
Tronson NC, Schrick C, Guzman YF, Huh KH, Srivastava DP, Penzes P et al (2009). Segregated populations of hippocampal principal CA1 neurons mediating conditioning and extinction of contextual fear. J Neurosci 29: 3387–3394.
Vidal-Gonzalez I, Vidal-Gonzalez B, Rauch SL, Quirk GJ (2006). Microstimulation reveals opposing influences of prelimbic and infralimbic cortex on the expression of conditioned fear. Learn Mem 13: 728–733.
Acknowledgements
The laboratory of MD is supported by DIUE de la Generalitat de Catalunya (Grups consolidats SGR 2014/1125). This work was supported by Fondation Jérôme Lejeune (Paris, France), MINECO (SAF2013-49129-C2-1-R and BFU2014-52467-R) and EU (Era Net Neuron PCIN-2013-060 and CORTICONIC 600806). The CRG is a Center of Excellence Severo Ochoa SEV-2012-0208. The CIBER of Rare Diseases is an initiative of the ISCIII. MS was supported by a postdoctoral fellowship by Fundação para a Ciência e Tecnologia (FCT, Portugal) and DD’A by La Caixa International PhD Programme fellowship.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
D'Amico, D., Gener, T., de Lagrán, M. et al. Infralimbic Neurotrophin-3 Infusion Rescues Fear Extinction Impairment in a Mouse Model of Pathological Fear. Neuropsychopharmacol 42, 462–472 (2017). https://doi.org/10.1038/npp.2016.154
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/npp.2016.154
This article is cited by
-
The amygdala NT3-TrkC pathway underlies inter-individual differences in fear extinction and related synaptic plasticity
Molecular Psychiatry (2024)
-
TrkC Intracellular Signalling in the Brain Fear Network During the Formation of a Contextual Fear Memory
Molecular Neurobiology (2023)
